Endeavor Health researchers develop more comprehensive genetic screening for heart disease risk
Researchers at Endeavor Health have developed the GenProb-CAD test, a new diagnostic tool that combines monogenic and polygenic screening to better assess coronary artery disease risk. The study, published in Circulation: Genomic and Precision Medicine, suggests this integrated approach provides a more comprehensive view of patient health.
Why it matters
Improved genetic screening could lead to earlier diagnosis and more personalized preventative care for heart disease, the leading cause of death in the U.S.
Test only clinically available at Endeavor Health; Results of study published in April's Circulation: Genomic and Precision Medicine journal
The article reports on medical research findings and clinical developments in a factual, objective manner.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in